Lindbrook Capital’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$191 Sell
22
-972
-98% -$10.2K ﹤0.01% 2707
2024
Q4
$12.1K Sell
994
-235
-19% -$3.29K ﹤0.01% 1552
2024
Q3
$20.7K Sell
1,229
-347
-22% -$5.71K ﹤0.01% 1283
2024
Q2
$24.6K Buy
1,576
+904
+135% +$12.6K ﹤0.01% 1124
2024
Q1
$10.6K Sell
672
-172
-20% -$2.88K ﹤0.01% 1542
2023
Q4
$17K Sell
844
-762
-47% -$12.9K ﹤0.01% 1273
2023
Q3
$29.8K Sell
1,606
-105
-6% -$2.29K ﹤0.01% 876
2023
Q2
$37.2K Buy
1,711
+134
+8% +$2.42K ﹤0.01% 813
2023
Q1
$29.2K Sell
1,577
-119
-7% -$2.24K ﹤0.01% 899
2022
Q4
$25.8K Buy
1,696
+1,598
+1,631% +$22.8K ﹤0.01% 946
2022
Q3
$1K Buy
98
+77
+367% +$1.55K ﹤0.01% 2417
2022
Q2
$1K Sell
21
-2
-9% -$54 ﹤0.01% 2303
2022
Q1
$1K Buy
+23
New +$827 ﹤0.01% 2300
2021
Q4
Sell
-56
Closed -$2K 2165
2021
Q3
$2K Sell
56
-32
-36% -$1.39K ﹤0.01% 1573
2021
Q2
$4K Buy
88
+76
+633% +$3.51K ﹤0.01% 1376
2021
Q1
$1K Buy
+12
New +$503 ﹤0.01% 1758
2020
Q4
Sell
-16
Closed -$1K 1841
2020
Q3
$1K Buy
+16
New +$612 ﹤0.01% 1598

Other funds holding NEOG

Lindbrook Capital's NEOG Position: Q1 2025 in Review

Lindbrook Capital reduced its Neogen (NEOG) stake by 98% in Q1 2025, selling an estimated $10.2K and leaving 22 shares worth $191. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

Lindbrook Capital first reported a position in NEOG in Q3 2020 and has held it in 17 quarters since. The position peaked at $37.2K in Q2 2023. 339 funds tracked by Wall St. Rank hold NEOG as of Q1 2025.

  • Lindbrook Capital held 22 shares of Neogen worth $191 as of Q1 2025.
  • Lindbrook Capital sold 972 Neogen shares in Q1 2025, an estimated $10.2K.
  • Neogen made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2707 holding.
  • Lindbrook Capital first reported a position in Neogen in Q3 2020 and has held it in 17 quarters since.
  • Lindbrook Capital's Neogen position peaked at $37.2K in Q2 2023.
  • 339 funds tracked by Wall St. Rank held Neogen as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.